Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2016, Article ID 9561494, 9 pages
http://dx.doi.org/10.1155/2016/9561494
Research Article

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy

1Department of Urology, University of Kentucky College of Medicine, Lexington, KY 40536, USA
2Department of Radiation Oncology, University of Kentucky College of Medicine, Lexington, KY 40536, USA
3University of Kentucky College of Medicine, Lexington, KY 40536, USA
4Department of Biostatistics, University of Kentucky College of Public Health, Lexington, KY 40536, USA
5Comprehensive Cancer Centers of Nevada, Las Vegas, NV 89169, USA

Received 21 October 2015; Revised 22 January 2016; Accepted 22 February 2016

Academic Editor: Hendrik Van Poppel

Copyright © 2016 John M. Lacy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. D. Arvold, M.-H. Chen, J. W. Moul et al., “Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease,” Journal of Urology, vol. 186, no. 1, pp. 91–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. D. Vassil, E. S. Murphy, C. A. Reddy et al., “Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation,” Urology, vol. 76, no. 5, pp. 1251–1257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. B. Malcolm, M. D. Fabrizio, B. B. Barone et al., “Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer,” The Journal of Urology, vol. 183, no. 5, pp. 1822–1829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Koukourakis, N. Kelekis, V. Armonis, and V. Kouloulias, “Brachytherapy for prostate cancer: a systematic review,” Advances in Urology, vol. 2009, Article ID 327945, 11 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Shekarriz, J. Upadhyay, and J. E. Pontes, “Salvage radical prostatectomy,” Urologic Clinics of North America, vol. 28, no. 3, pp. 545–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Russo, “Salvage radical prostatectomy after radiation therapy and brachytherapy,” Journal of Endourology, vol. 14, no. 4, pp. 385–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. K. E. Wallner, D. Nori, M. J. Morse, P. C. Sogani, W. F. Whitmore, and Z. Fuks, “125Iodine reimplantation for locally progressive prostatic carcinoma,” Journal of Urology, vol. 144, no. 3, pp. 704–706, 1990. View at Google Scholar · View at Scopus
  8. P. Koutrouvelis, F. Hendricks, N. Lailas et al., “Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant,” Technology in Cancer Research and Treatment, vol. 2, no. 4, pp. 339–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Roach III, G. Hanks, H. Thames Jr. et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology, Biology, Physics, vol. 65, pp. 965–974, 2006. View at Google Scholar
  10. A. V. D'Amico, R. Whittington, S. Bruce Malkowicz et al., “Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer,” Journal of the American Medical Association, vol. 280, no. 11, pp. 969–974, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. W. R. Lee, G. E. Hanks, and A. Hanlon, “Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations,” Journal of Clinical Oncology, vol. 15, no. 1, pp. 230–238, 1997. View at Google Scholar · View at Scopus
  12. F. J. Bianco Jr., P. T. Scardino, A. J. Stephenson, C. J. DiBlasio, P. A. Fearn, and J. A. Eastham, “Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 62, no. 2, pp. 448–453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. F. Ward, T. J. Sebo, M. L. Blute, and H. Zincke, “Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes,” Journal of Urology, vol. 173, no. 4, pp. 1156–1160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. L. L. Pisters, D. Leibovici, M. Blute et al., “Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy,” The Journal of Urology, vol. 182, no. 2, pp. 517–527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. J. Stephenson and J. A. Eastham, “Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy,” Journal of Clinical Oncology, vol. 23, no. 32, pp. 8198–8203, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. D. C. Chade, S. F. Shariat, A. M. Cronin et al., “Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration,” European Urology, vol. 60, no. 2, pp. 205–210, 2011. View at Publisher · View at Google Scholar
  17. P. L. Nguyen, M.-H. Chen, A. V. D'Amico et al., “Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study,” Cancer, vol. 110, no. 7, pp. 1485–1492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. L. L. Pisters and J. F. Ward, “Salvage therapy after primary non-surgical therapy for prostate cancer,” AUA Update Series, vol. 33, lesson 2, 2014. View at Google Scholar
  19. M. Ismail, S. Ahmed, C. Kastner, and J. Davies, “Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients,” BJU International, vol. 100, no. 4, pp. 760–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. L. Pisters, J. C. Rewcastle, B. J. Donnelly, F. M. Lugnani, A. E. Katz, and J. S. Jones, “Salvage prostate cryoablation: initial results from the cryo on-line data registry,” Journal of Urology, vol. 180, no. 2, pp. 559–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. B. Galosi, F. Lugnani, and G. Muzzonigro, “Salvage cryosurgery for recurrent prostate carcinoma after radiotherapy,” Journal of Endourology, vol. 21, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kanthabalan, M. Arya, S. Punwani et al., “Role of focal salvage ablative therapy in localised radiorecurrent prostate cancer,” World Journal of Urology, vol. 31, no. 6, pp. 1361–1368, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F.-J. Murat, L. Poissonnier, M. Rabilloud et al., “Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer,” European Urology, vol. 55, no. 3, pp. 640–649, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Crouzet, S. Brown, and V. Berge, “Multicentric oncologic outcomes of salvage HIFU for local failure after external beam radio therapy: 7 years biochemical survival of 929 patients,” in Proceedings of the 27th Annual European Association of Urology Congress, Paris, France, 2012.
  25. H. U. Ahmed, A. Ishaq, E. Zacharakis et al., “Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy,” BJU International, vol. 103, no. 3, pp. 321–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Burri, N. N. Stone, P. Unger, and R. G. Stock, “Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer,” International Journal of Radiation Oncology Biology Physics, vol. 77, no. 5, pp. 1338–1344, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Vargas, D. Swartz, A. Vashi et al., “Salvage brachytherapy for recurrent prostate cancer,” Brachytherapy, vol. 13, no. 1, pp. 53–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Lee, K. Shinohara, V. Weinberg et al., “Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience,” International Journal of Radiation Oncology, Biology, Physics, vol. 67, no. 4, pp. 1106–1112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Jo, T. Fujii, R. Hara et al., “Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy-Preliminary results,” BJU International, vol. 109, no. 6, pp. 835–839, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tharp, M. Hardacre, R. Bennett, W. T. Jones, D. Stuhldreher, and J. Vaught, “Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer,” Brachytherapy, vol. 7, no. 3, pp. 231–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. C. Blasko, P. D. Grimm, and H. Ragde, “Brachytherapy and organ preservation in the management of carcinoma of the prostate,” Seminars in Radiation Oncology, vol. 3, no. 4, pp. 240–249, 1993. View at Publisher · View at Google Scholar · View at Scopus
  32. P. D. Grimm, J. C. Blasko, and H. Radge, “Ultrasound-guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer; technical concepts in planning, operative technique and evaluation,” Atlas of the Urologic Clinics of North America, vol. 2, pp. 113–125, 1994. View at Google Scholar
  33. D. W. Smith, D. Stoimenova, K. Eid, and A. Barqawi, “The role of targeted focal therapy in the management of low-risk prostate cancer: update on current challenges,” Prostate Cancer, vol. 2012, Article ID 587139, 5 pages, 2012. View at Publisher · View at Google Scholar
  34. B. Tareen, G. Godoy, A. Sankin, S. Temkin, H. Lepor, and S. S. Taneja, “Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?” BJU International, vol. 104, no. 2, pp. 195–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. A. V. Taira, G. S. Merrick, R. W. Galbreath et al., “Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting,” Prostate Cancer and Prostatic Diseases, vol. 13, no. 1, pp. 71–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. E. McNeal, E. A. Redwine, F. S. Freiha, and T. A. Stamey, “Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread,” The American Journal of Surgical Pathology, vol. 12, no. 12, pp. 897–906, 1988. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Tran, J. Thompson, M. Böhm et al., “Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy,” BJU International, vol. 117, no. 1, pp. 48–54, 2016. View at Publisher · View at Google Scholar
  38. M. Abd-Alazeez, H. U. Ahmed, M. Arya et al., “The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—can it rule out clinically significant prostate cancer?” Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 1, Article ID e17-22, p. 45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Chondrogiannis, M. C. Marzola, A. Ferretti et al., “Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, no. 9, pp. 1356–1364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Beheshti, S. Haim, R. Zakavi et al., “Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics,” Journal of Nuclear Medicine, vol. 54, no. 6, pp. 833–840, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Tombal and F. Lecouvet, “Modern detection of prostate cancer's bone metastasis: is the bone scan era over?” Advances in Urology, vol. 2012, Article ID 893193, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus